On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of ...

Cardiff-based Health and Her is poised for significant growth in the US with its menopause dietary supplements now available ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

UAE retail investors are showing strong conviction in the long-term potential of electric vehicles and emerging tech, with ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.